









Markets
/
Stocks
/
nasdaq-nams
/

NewAmsterdam Pharma Company NV

NAMS

35.110USD

+1.210+3.57%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

3.97BMarket Cap

LossP/E TTM



NewAmsterdam Pharma Company NV

35.110

+1.210+3.57%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of NewAmsterdam Pharma Company NV to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q3

FY2023Q2

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-162.11%-32.77M

30.21%-37.67M

33.21%-36.47M

---37.48M

73.39%-12.50M

-84.20%-53.98M

-71.36%-54.60M

---46.98M

---29.30M

---31.86M

Net income from continuing operations

-332.54%-72.00M

55.48%-17.36M

57.85%-39.53M

---92.18M

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

---47.13M

---38.29M

---42.02M

Operating gains losses

128.57%64.00K

136.84%45.00K

246.67%52.00K

--51.00K

100.00%28.00K

46.15%19.00K

66.67%15.00K

--14.00K

--13.00K

--9.00K

Other non-cash items

86.87%-614.00K

-1013.45%-9.10M

-298.55%-4.80M

--7.64M

-248.15%-4.68M

1264.38%996.00K

178.92%2.42M

--3.16M

--73.00K

---3.06M

Change in working capital

3410.71%983.00K

-63.48%-23.84M

202.11%10.35M

---7.98M

100.48%28.00K

-587.47%-14.59M

-1647.76%-10.14M

---5.88M

--2.99M

---580.00K

-Change in prepaid expenses

630.22%2.61M

-136.80%-21.86M

1576.88%16.03M

---8.69M

83.84%-493.00K

-269.36%-9.23M

167.66%956.00K

---3.05M

--5.45M

---1.41M

-Change in other current liabilities

100.00%0.00

-32.95%-3.03M

-112.56%-2.98M

--1.51M

39.29%-1.79M

-32.73%-2.28M

56.81%-1.40M

---2.94M

---1.72M

---3.24M

Cash from non-recurring investing activities

Cash from operating activities

-162.11%-32.77M

30.21%-37.67M

33.21%-36.47M

---37.48M

73.39%-12.50M

-84.20%-53.98M

-71.36%-54.60M

---46.98M

---29.30M

---31.86M

Investing cash flow

Net cash from continuing investing activities

-44.00%42.00K

-57.89%88.00K

-95.84%16.00K

--3.00K

733.33%75.00K

4080.00%209.00K

5400.00%385.00K

--9.00K

--5.00K

--7.00K

Capital expenditures

-44.00%42.00K

-57.89%88.00K

-95.84%16.00K

--3.00K

733.33%75.00K

4080.00%209.00K

5400.00%385.00K

--9.00K

--5.00K

--7.00K

Net cash flow from disposal of fixed assets

-44.00%42.00K

-57.89%88.00K

-95.84%16.00K

--3.00K

733.33%75.00K

4080.00%209.00K

5400.00%385.00K

--9.00K

--5.00K

--7.00K

Net cash flow from investment products

--2.55M

---159.05M

--2.87M

---62.18M

----

Cash from non-current investing activities

Net cash flow from investing activities

3441.33%2.51M

-76041.63%-159.14M

841.56%2.85M

---62.18M

-733.33%-75.00K

-4080.00%-209.00K

-5400.00%-385.00K

---9.00K

---5.00K

---7.00K

Financing cash flow

Cash flow from continuous financing activities

10058.62%5.89M

-26.47%3.42M

-96.71%6.52M

--456.61M

-68.82%58.00K

-26.46%4.66M

8185.12%198.18M

--186.00K

--6.33M

--2.39M

Net cash flow from common stock issuance/repurchase

----

--0.00

----

--455.03M

--0.00

--190.48M

----

--0.00

Proceeds from stock option exercised by employees

9586.21%5.62M

--3.42M

1700.45%7.92M

--1.27M

-68.65%58.00K

-100.00%0.00

--440.00K

--185.00K

--105.00K

--0.00

Proceeds from issuance of warrants

--274.00K

-99.98%1.00K

-97.91%183.00K

--340.00K

-100.00%0.00

-25.22%4.66M

266.35%8.76M

--1.00K

--6.23M

--2.39M

Net cash flow from other financing activities

--0.00

-5.45%-1.59M

---25.00K

--0.00

---1.50M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

10058.62%5.89M

-26.47%3.42M

-96.71%6.52M

--456.61M

-68.82%58.00K

-26.46%4.66M

8185.12%198.18M

--186.00K

--6.33M

--2.39M

Net cash flow

Beginning cash balance

30.92%563.86M

55.55%748.42M

126.68%771.74M

--422.73M

3.36%430.71M

9.03%481.15M

-27.21%340.45M

--416.71M

--441.31M

--467.73M

Current period cash flow changes

-202.66%-24.15M

-265.90%-184.56M

-116.58%-23.32M

--349.01M

83.51%-7.98M

-104.99%-50.44M

632.62%140.70M

---48.40M

---24.61M

---26.42M

Effect of exchange rate changes

-95.11%222.00K

1070.96%8.83M

251.08%3.77M

---7.94M

383.75%4.54M

44.23%-909.00K

-181.52%-2.50M

---1.60M

---1.63M

--3.06M

Ending cash balance

27.67%539.72M

30.92%563.86M

55.55%748.42M

--771.74M

14.78%422.73M

3.36%430.71M

9.03%481.15M

--368.31M

--416.71M

--441.31M

Free cash flow

-160.88%-32.81M

30.32%-37.76M

33.65%-36.48M

---37.48M

73.23%-12.58M

-84.88%-54.19M

-72.54%-54.99M

---46.98M

---29.31M

---31.87M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

